Emerging agents and regimens for cancer therapy
CAR T-cell therapy for cancer and HIV through novel approaches to HIV-associated haematological malignancies - The Lancet Haematology
CAR-T Cells: Driving a New Era of Oncology Immunotherapy
Mechanisms of resistance to CAR T cell therapy. - Nat. Rev. Clin. Oncol. - X-MOL
Gene modification strategies for next-generation CAR T cells against solid cancers | Journal of Hematology & Oncology | Full Text
King's Health Partners News
In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes: Molecular Therapy
Carl June: The World's First CAR-T Therapy Released the Latest Data – Creative Biolabs CAR-T Blog
Weighing the Cost and Value of CAR T-Cell Therapy - The ASCO Post
CAR T cell therapy: A new era for cancer treatment (Review)
King's Health Partners News
The Principles of Engineering Immune Cells to Treat Cancer: Cell
Immunotherapy takes cancer treatment into a new era | CTCA
CAR-T Therapy - OHC - Oncology Hematology Care
CAR T cell immunotherapy for human cancer | Science
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer - European Urology
A guide to cancer immunotherapy: from T cell basic science to clinical practice | Nature Reviews Immunology
Immuno-oncology agents for cancer therapy | Review article | Pharmaceutical Journal
Genetically engineered T cells for cancer immunotherapy | Signal Transduction and Targeted Therapy
CAR T cell therapy: A new era for cancer treatment (Review)
Frontiers | Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells | Immunology
Crafting a More Efficient CAR T-Cell Industry
A new era of medicine | Novartis
FDA Approves Second CAR T-Cell Therapy | The Scientist Magazine®
CAR T-cell Therapy: A New Era in Cancer Immunotherapy | Bentham Science
PDF) CAR T cell therapy: A new era for cancer treatment (Review)
